SIRT3 and colonic neoplasm: In vitro studies showed that silencing SIRT3 in colon cancer cells resulted in an increase in oxidative burden, changes of the mitochondrial biogenesis, inhibition of cell proliferation and increased activation of apoptosis, thus consequently sensitizing cells to cytotoxic treatments [10,11,12].